Wolters Kluwer N.V. WKL.AS
Composite 54/100; the shares have moved about 40% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Balance-sheet strength ranks 28/100 — a moderate mark against it.
Quality ranks 82/100 — a strong point in its favour. Income ranks 80/100 — a strong point in its favour. Valuation ranks 63/100 — a moderate point in its favour.
Balance-sheet strength ranks 28/100 — a moderate mark against it. Momentum ranks 33/100 — a moderate mark against it. Growth ranks 44/100 — a slight mark against it.
What the company does Wolters Kluwer provides specialized information, software, and services to professionals across Health, Tax & Accounting, Financial & Corporate Compliance, Legal & Regulatory, and Corporate Performance & ESG segments. Its AI-powered solutions serve healthcare, finance, and regulatory markets globally.
Key financials The company exhibits strong profitability with ROE 112%, ROA 10%, and ROCE 53%. Margins are robust: gross 73%, operating 24%, and net 21%. Revenue growth is modest at 2%, but EPS growth is high at 37%. Debt metrics are manageable with a debt/equity of 6.23 and interest coverage of 20x.
Stock health Quality and income scores are excellent at 84 and 84, respectively, but momentum is weak (29). The stock is down 42% from its 52-week high and has an RSI of 78, indicating overbought conditions. The Piotroski F-Score is 7/9, and Altman Z-score is 3.4, suggesting low bankruptcy risk.
Price vs fair value The stock trades at a **discount** of 52% to our fair-value estimate and a **discount** of 24% to the analyst target. - Trading at a steep discount to both fair value (52%) and analyst target (24%) (Sideravia). - High profitability (ROE 112%) contrasts with weak momentum (-42% from 52-week high) (Sideravia). - RSI of 78 signals overbought conditions despite the discount (Sideravia). - Modest revenue growth (2%) but strong EPS growth (37%) (Sideravia).
Looking forward Forward P/E of 13x and EV/EBITDA of 9x suggest undemanding valuations. Analysts see potential upside to 92, though momentum remains a near-term headwind. Dividend yield is 3.5% with a sustainable payout ratio of 43%.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.